Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus

Carette S, Klippel JH, Decker JL et al (1983) Controlled studies of oral immunosuppressive drugs in lupus nephritis. A long-term follow-up. Ann Intern Med 99:1–8

Jayne D, Rasmussen N, Andrassy K et al (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349:36–44

Jeurissen ME, Boerbooms AM, van de Putte LB (1988) Pancytopenia related to azathioprine in rheumatoid arthritis. Ann Rheum Dis 47:503–505

Ngo S, Sauvetre G, Vittecoq O, Levesque H, Marie I (2011) Azathioprine-associated severe myelosuppression: indication of routine determination of thiopurine S-methyltransferase variant? Rev Med Interne 32:373–376

Boonsrirat U, Angsuthum S, Vannaprasaht S et al (2008) Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism. Lupus 17:132–134

Otterness D, Szumlanski C, Lennard L et al (1997) Human thiopurine methyltransferase pharmacogenetics: gene sequence polymorphisms. Clin Pharmacol Ther 62:60–73

Cyrus N, Stavert R, Mason AR, Ko CJ, Choi JN (2013) Neutrophilic dermatosis after azathioprine exposure. JAMA Dermatol 149:592–597

Colleoni L, Kapetis D, Maggi L et al (2013) A new thiopurine s-methyltransferase haplotype associated with intolerance to azathioprine. J Clin Pharmacol 53:67–74

Larussa T, Suraci E, Lentini M et al (2012) High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease. Eur J Intern Med 23:273–277

Winter JW, Gaffney D, Shapiro D et al (2007) Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease. Aliment Pharmacol Ther 25:1069–1077

Corominas H, Domenech M, del Río E, Gich I, Domingo P, Baiget M (2006) Frequency of thiopurine S-methyltransferase alleles in different ethnic groups living in Spain. Med Clin (Barc) 126:410–412

Okada Y, Nakamura K, Kodama T et al (2005) Thiopurine methyltransferase genotype and phenotype status in Japanese patients with systemic lupus erythematosus. Biol Pharm Bull 28:2117–2119

Xiong H, Xin HW, Wu XC, Li Q, Xiong L, Yu AR (2010) Association between inosine triphosphate pyrophosphohydrolase deficiency and azathioprine-related adverse drug reactions in the Chinese kidney transplant recipients. Fundam Clin Pharmacol 24:393–400

Fangbin Z, Xiang G, Minhu C et al (2012) Should thiopurine methyltransferase genotypes and phenotypes be measured before thiopurine therapy in patients with inflammatory bowel disease. Ther Drug Monit 34:695–701

Zhang JP, Guan YY, Wu JH, Xu AL, Zhou S, Huang M (2004) Phenotyping and genotyping study of thiopurine S-methyltransferase in healthy Chinese children: a comparison of Han and Yao ethnic groups. Br J Clin Pharmacol 58:163–168

Kroplin T, Weyer N, Gutsche S, Iven H (1998) Thiopurine S-methyltransferase activity in human erythrocytes: a new HPLC method using 6-thioguanine as substrate. Eur J Clin Pharmacol 54:265–271

Xin H, Fischer C, Schwab M, Klotz U (2005) Effects of aminosalicylates on thiopurine S-methyltransferase activity: an ex vivo study in patients with inflammatory bowel disease. Aliment Pharmacol Ther 21:1105–1109

Newman WG, Payne K, Tricker K et al (2011) A pragmatic randomized controlled trial of thiopurine methyltransferase genotyping prior to azathioprine treatment: the TARGET study. Pharmacogenomics 12:815–826

Yan L, Zhang S, Eiff B et al (2000) Thiopurine methyltransferase polymorphic tandem repeat: genotype–phenotype correlation analysis. Clin Pharmacol Ther 68:210–219

Srimartpirom S, Tassaneeyakul W, Kukongviriyapan V, Tassaneeyakul W (2004) Thiopurine S-methyltransferase genetic polymorphism in the Thai population. Br J Clin Pharmacol 58:66–70

McLeod HL, Siva C (2002) The thiopurine S-methyltransferase gene locus—implications for clinical pharmacogenomics. Pharmacogenomics 3:89–98

Schaeffeler E, Fischer C, Brockmeier D et al (2004) Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics 14:407–417

Colombel JF, Ferrari N, Debuysere H et al (2000) Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy. Gastroenterology 118:1025–1030

Hindorf U, Lindqvist M, Hildebrand H, Fagerberg U, Almer S (2006) Adverse events leading to modification of therapy in a large cohort of patients with inflammatory bowel disease. Aliment Pharmacol Ther 24:331–342